Thibault Honegger, PDG et Co-Fondateur de NETRI, dans Le Magazine Biovalley France
NETRI has developed key and unique technologies that allow to produce reproducible, close to human physiopathology, reliable and easy to use organ-on-chip!
NETRI has developed key and unique technologies that allow to produce reproducible, close to human physiopathology, reliable and easy to use organ-on-chip!
NETRI has developed key and unique technologies that allow to produce reproducible, close to human physiopathology, reliable and easy to use organ-on-chip!
NETRI has developed key and unique technologies that allow to produce reproducible, close to human physiopathology, reliable and easy to use organ-on-chip!
L'occasion pour NETRI et ses experts scientifiques de présenter sa vision et le rôle des organes-sur-puce dans le développement de nouveaux médicaments.
NETRI sera présent à la prochaine édition de "1 verre 1 job" de H7, le jeudi 17 mars
NETRI in 5 Top Emerging Organ-on-a-Chip (OOC) Startups Impacting The Pharma Sector by StartUs Insight
La start-up industrielle lyonnaise NETRI finalise un tour de table de série A de 8 millions d’euros. Ce financement permettra à NETRI d’accélérer le développement de ses unités de production pilotes de dispositifs microfluidiques et de cultures cellulaires humaines afin de soutenir sa croissance, devenir le leader mondial industriel d’organes-sur-puce et d’étendre ses domaines [...]
The Lyon-based industrial start-up NETRI finalizes a Series A of €8 million fundraising round. This financing will allow NETRI to accelerate the development of its pilot production units for microfluidic devices and human-cell cultures in order to support its growth, become the world industrial leader in organs-on-chip and to expand its fields of [...]
NETRI has developed key and unique NeuroFluidics™ products that allow to challenge the way we discover new treatments with a mutlidisciplinary, simple to use and user friendly approach!
NETRI est présentée par Frédéric Llop et Marie Redortier au JT de France 3 Région à travers une interview de Thibault Honegger, PDG & Co-Fondateur et une visite de ses laboratoires de production et de biologie cellulaire.